PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer
Abstract The outlook for patients with pancreatic cancer remains dismal. Treatment options are limited and chemotherapy remains standard of care, leading to only modest survival benefits. Hence, there is a great need to further explore the mechanistic basis for the intrinsic therapeutic resistance o...
Saved in:
Main Authors: | Sofie Olsson Hau (Author), Sara Wahlin (Author), Sophie Cervin (Author), Vilgot Falk (Author), Björn Nodin (Author), Jacob Elebro (Author), Jakob Eberhard (Author), Bruce Moran (Author), William M Gallagher (Author), Emelie Karnevi (Author), Karin Jirström (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
by: Nodin Björn, et al.
Published: (2012) -
Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma
by: Gustav Andersson, et al.
Published: (2019) -
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer
by: Nina Andersson, et al.
Published: (2020) -
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
by: Bjartell Anders, et al.
Published: (2011) -
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
by: Nodin Björn, et al.
Published: (2012)